We found 2 result(s) that match your search "Report Cards":Search Results
January 3rd 2008 @ 10:59 am by Nicole Purcell
Categories: Type 1
Tags: 2007 Report Cards Resolutions Tardiness
Views: 1201
Categories: Type 1
Tags: 2007 Report Cards Resolutions Tardiness
Views: 1201
Per usual, I'm tardy.
Resolution #1 in the New Year: I shall try to be more timely.
Actually, I'm not making any resolutions this year. I think I've turned a corner in terms of resolving to lose weight, exercise, eat right, and relax - then not doing any of it. The difference for me in 2007 was that I promised to do nothing - and I did most of the things I would have promised to do if I'd made resolutions.
Go figure.
At the close of December, the year found me down 30 lbs, exercising more and with more vigor than I have since my teens, eating right and enjoying it, in a new - more satisfying - job, getting paid to write (how exciting!). Numbers-wise, I finished the year with an average A1C of 5.7% and my cholesterol levels much lower. (READ MORE)
| Rating (0) | Email this Comments (3) |
October 3rd 2007 @ 9:33 am by Carey Potash
Categories: Type 1 In the News
Tags: business of diabetes new drug sales
Views: 943
Categories: Type 1 In the News
Tags: business of diabetes new drug sales
Views: 943
I found a recent article disturbing. A large drugmaker estimates that three diabetes drugs in the pipeline have the potential to bring in sales of $3 billion in the next few years.
I could have looked at the upside of this. These are drugs that could improve the quality of life and health of many people living with diabetes.
I could have.
But what I see in this article is a positive report on the financials of a company getting a little richer every time another person gets diagnosed. News that panders to its shareholders and seems just a bit too pleased about having so many people with diabetes to treat. I see my son as a client in the business of diabetes. He's their demographic; he's the customer.
"You're talking peak sales in the multiple billions for all three drugs, if they succeed," an analyst from Miller Tabak & Co. said. (READ MORE)
| Rating (0) | Email this Comments (4) |














